XORTX Therapeutics XRTX
NASDAQ XRTX
$0.95 -0.04 (-4.30%)
As of: Oct 21, 2026 · 2:59 PM EDT

XORTX Therapeutics (XRTX) EBT Margin (2023)

Updated

Analysis

XORTX Therapeutics (XRTX) EBT Margin (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 26.66%
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 25.18%
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn -4.11%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn 18.19%
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 27.53%
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn -131.41%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -4.34%
10 XORTX Therapeutics 924,958.32 -2.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 74.81%
Sep 30, 2023 -104.50%
Jun 30, 2023 -74.45%
Mar 31, 2023 -73.97%
API Access

XORTX Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=XRTX&period=max&api_key=YOUR_API_KEY